人胃腺癌组织中RUNX3、EGFR、VEGF表达及意义

来源 :第十三届全国胃癌学术会议 | 被引量 : 0次 | 上传用户:wyn6098
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的 观察RUNX3、EGFR、VEGF 在人胃腺癌组织中的表达,探讨其与胃癌淋巴转移和血管侵犯中的关系。方法 采用免疫组织化学EliVision 法检测122 例人胃腺癌组织中RUNX3、EGFR、VEGF 的蛋白表达水平,分析其与胃腺癌临床病理特征的关系。
其他文献
目的 探索肿瘤相关成纤维分泌的HGF 在胃癌中对血管化的作用及其潜在机制。方法 采用ELISA 、qRT-PCR 和western blots 分析胃癌细胞系、人脐静脉内皮细胞(HUVEC)及肿瘤相关成纤维细胞中HGF 和c-Met 的表达。采用CCK-8 试剂及建立共培养体系分别检测肿瘤相关成纤维细胞分泌的HGF 对HUVECs 及胃癌细胞增殖和迁移的影响。
Objective The purpose of this study is to illustrate the key role and biological mechanisms of HER4-YAP1 axis promoting trastuzumab resistance in HER2-positive gastric cancer cells by inducing epithel
Objective Gastric cancer is one of the most common malignancy and the third dominant cause of cancer death worldwide.The prognosis of GC is very poor and the five-year survival is less than 30%.
Objective The study was designed to assay the expression of Thymidylate Synthase(TS)on freshly-removed gastric cancer tissues and analyze its significance in predicting the prognosis.
Objective The prognostic significance of preoperative plasma fibrinogen in patients with operable gastric cancer remains under debate.This study aims to elucidate the prognostic value of fibrinogen in
Objective Tumor metastasis is the leading cause of deaths in advanced gastric cancer(GC)with limited therapeutic options and poor prognosis,and the underlying mechanisms for tumor metastasis remain un
Objective Recurrence and metastasis are always the major factors affecting the prognosis of patients of gastric cancer.According to the references in the recent years,fatty acids contributes to the me
Objective To investigate the anti-tumor effect and mechanisms of Modified Liang-Fu Granules(MLFG)on gastric cancer cell proliferation and apoptosis.
Objective In addition to blocking the growth of tumor blood vessels,antiangiogenic agents also promote antitumor immunity.Vascular epithelial growth factor receptor 2(VEGFR2)inhibitor YN968D1 is a hig
目的 近些年,在消化道肿瘤中,胃癌的发病率已经居于首位,而其所导致的死亡率已上升为全球第二位,在国内每年因胃癌死亡的比例接近25.32/10 万.